Skip to main content Deutsch

News

Triapine: A promising approach to support cancer therapy through activation of the immune system

In a recent study, researchers at the Medical University of Vienna, in collaboration with the University of Vienna, investigated the immunostimulatory…

Rethinking Cancer – An evening dedicated to research, responsibility, and networking

In September, the Comprehensive Cancer Center (CCC) Vienna of the Medical University of Vienna and the Vienna General Hospital invited guests to a…

September 7: World Radiotherapy Awareness Day: A voice for radiation oncology

Cancer can often only be cured with radiation therapy, which also plays an important role in alleviating cancer-related symptoms. Using…

Safe use of immunotherapy in combination with chemoradiotherapy for rectal cancer

Combination of ipilimumab and nivolumab with chemoradiotherapy shows no increased surgical risks

Owkin and The Comprehensive Cancer Center of the Medical University of Vienna Announce Strategic Collaboration to Accelerate Cancer Research and Care with AI Copilot

Paris and Vienna, 19 August 2025 — Owkin, a leading agentic AI company, and the Comprehensive Cancer Center of the Medical University of Vienna…

Vienna Summer School on Oncology successfully completed

More than 30 participants from 11 countries around the world were welcomed to the Medical University of Vienna for the Vienna Summer School on…

Working together against cancer: Austrian Comprehensive Cancer Network and Bavarian Centre for Cancer Research launch cooperation

University, Medicine & Science

Cross-border alliance for a regional cancer research and care network as part of the EU Mission Cancer

Microplastics can cause malignant changes in lung cells

Study reveals previously unknown effects of plastic particles on the lungs

 

Novel tRNA fragments enable prognosis for liver metastases for the first time

Researchers at MedUni Vienna discover new biomarkers for prognosis assessment in liver metastases from colorectal cancer

Increased risk of muscle damage when combining immunotherapy and chemoradiation in rectal cancer

Early diagnosis and targeted treatment are crucial to avoiding serious complications.